HBsAg Seroclearance: The More and Earlier, the Better

Gastroenterology

Volumn 136, Issue 5, 2009, Pages 1842-1843

  Tseng, Tai Chung ^a   Kao, Jia Horng ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b Graduate Institute of Clinical Medicine   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

CANCER RISK; CHRONIC HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FIBROSIS; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; VIRUS CARRIER; VIRUS REPLICATION;

EID: 65349193776     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.12.074     Document Type: Letter

References (8)

1. Yuen M.F., Wong D.K., Fung J., et al. HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 135 (2008) 1192-1199
2. Kao J.H., and Chen D.S. Universal hepatitis B vaccination: killing 2 birds with 1 stone. Am J Med 121 (2008) 1029-1031
3. Lok A.S., and McMahon B.J. Chronic hepatitis B. Hepatology 45 (2007) 507-539
4. Kao J.H., and Chen D.S. Global control of hepatitis B virus infection. Lancet Infect Dis 2 (2002) 395-403
5. Liaw Y.F., Sheen I.S., Chen T.J., et al. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 13 (1991) 627-631
6. Hsu H.Y., Chang M.H., Lee C.Y., et al. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 15 (1992) 382-386
7. Chu C.M., and Liaw Y.F. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 45 (2007) 1187-1192
8. Block T.M., Guo H., and Guo J.T. Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis 11 (2007) 685-706